Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04295876 · ClinicalTrials.gov registry record · NA

The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support Services

A NA study of HIV/AIDS, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04295876: Completed NA study of HIV/AIDS, sponsored by University of California, San Diego.

NCT04295876 is a NA study of HIV/AIDS that has completed, run by University of California, San Diego. The registered enrollment target is 24 participants, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04295876, a NA study of HIV/AIDS, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The BRIDGES Project seeks to test a program intended to help women living with HIV who face specific barriers due to culture, gender, violence, trauma, adverse mental health, and substance use to be able to better access HIV care. This program was created and tried with women living with HIV, as previously studies have indicated that women with these experiences are less likely to have stable HIV care. The BRIDGES Project will use Peer Navigators, who are other women living with HIV who have had similar experiences and have been successful in accessing care, to help other women living with HIV to access HIV care and stay in HIV care. The BRIDGES Project will also provide support to women through group sessions co-facilitated by a licensed clinical therapist and Peer Navigator. Through participation in BRIDGES, women will: (1) build skills to cope with HIV care and treatment barriers (e.g., violence, trauma, adverse mental health, substance use); (2) be connected to HIV treatment and other support services (e.g., domestic violence, mental health, substance use); and (3) learn interpersonal skills to connect with support (e.g., service providers, peers, friends, family) when faced with new or ongoing barriers.

Primary Outcome

Documentation of a clinical visit date with an ART-prescribing provider (yes, no), assessed by medical record extraction; days to first clinical visit since baseline (continuous), assessed by medical record extraction

Conditions Studied

Interventions

  • BEHAVIORAL The BRIDGES Project Intervention

Study Locations (1)

California

  • UCSD Webster Building - San Diego

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2019-12-19
Est. Completion 2021-01-01
Phase NA
University of California, San Diego

775 total trials

What the finished NCT04295876 record still lists

NCT04295876 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 33,180-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower).

The record links to 1 condition, with HIV/AIDS appearing as the primary indexed condition, and to 1 intervention - of which The BRIDGES Project Intervention is the first listed.

NCT04295876 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT04295876 about?

NCT04295876 is a clinical study titled "The BRIDGES Project: Bridging Resources to Engage Women in Integrated HIV Care and Support Services". The BRIDGES Project seeks to test a program intended to help women living with HIV who face specific barriers due to culture, gender, violence, trauma, adverse mental health, and substance use to be able to better access HIV care. This program was created and tried with women living with HIV, as pre...

What is the current status of trial NCT04295876?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2019-12-19. Estimated completion is 2021-01-01.

What conditions does trial NCT04295876 study?

This clinical trial studies the following conditions: HIV/AIDS.

What interventions are being tested in trial NCT04295876?

The interventions under investigation include: The BRIDGES Project Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04295876?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04295876 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04295876's enrollment target sits among peer trials

24 56th of 61 higher than 5 of 61 other HIV/AIDS trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV/AIDS trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04295876, the US trial registry maintained by the National Library of Medicine. NCT04295876 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.